|
Vol. 34 Nş 3 |
Lat. Am. J. Pharm. 34 (3): 425-636 (2015) |
REGULAR ARTICLES |
|
|
Design and Optimization of Controlled Release Ketoprofen Tablets *
ZAFAR F., SHOAIB M.H., ALI H. & ALAM Z.M. (429)
|
|
|
|
Pharmacobotanical Characters of Mikania micrantha (Asteraceae) and its Support for Quality Control *
ARAUJO F.F., AMORIN M., dos SANTOS V.L.P., FRANCO C.R.C., FOLQUITTO D.G., da SILVA R.Z., FARAGO P.V., TAKEDA I.J.M., NAKASHIMA T. & BUDEL J.M. (437)
|
|
|
|
Determination of Terbinafine and its Main Metabolite in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study *
ZHOU Y., WANG S., GENG P., PAN P., WEI M., HU G. & LU X. (443)
|
|
|
|
HPLC Method for Simultaneous Determination of Entecavir and Tenofovir in Human Spiked Plasma and Pharmaceutical Dosage Forms *
ALTAF H., ASHRAF M., HAYAT M.M., HUSSAIN A., ALI Y., SHAHZAD N., AHMAD M.B., RAHMAN J., AKHTAR N., & REHMAN S. (449)
|
|
|
|
Development and Validation of an HPLC Method for the Quantification of Sitagliptin in Plasma and Tablet Dosage Form *
ASHRAF M., SHAHZAD M.N., HAYAT M.M., RAHMAN J., EJAZ S., ALTAF H. & NASIM F.H. (456)
|
|
|
|
Pharmacokinetic Study of Icariin in Rat by UPLC-MS/MS *
WU C., WANG S., GENG P., SHEN H., HAN A. & ZHOU Y. (462)
|
|
|
|
Neutralizing Ability of Bioactive Glass (BG) on the PLGA Microsphere Degradation *
CAO J., SHI S., GENG H., DONG Y., JI L., XU Y. & LIU H. (468)
|
|
|
|
A New Anti-Inflammatory Triterpenoid Saponin from Penthorum chinense Pursh *
WANG Y., WANG Y., LIU B., YUAN L., CHEN J., BAO J. & GUO M. (474)
|
|
|
|
An Investigation of the Off-Label Use of Bevacizumab *
LIU T., CHEN Z., LIN Z., CHEN F. & HUANG H. (480)
|
|
|
|
Taste-Masked Spray Dried Microparticles for Intra-Oral Dispersible Tablets of Lornoxicam *
SHAZLY G.A., IBRAHIM M.A., AUDA S.H., EL-BADRY M., AL-SUWAYEH S.A. & SHAKEEL F. (488)
|
|
|
|
Design, Evaluation and Optimization by Central Composite Design of Effervescent Floating Tablets of Norfloxacin Using Natural Polymers *
ASGHAR A., SETHI A., WAQAS H.M., ISHFAQ B., NOOR H., HANIF M. & AWAN M.A.B. (496)
|
|
|
|
A Simple HPLC Method for Determining Enoxacin in Human Plasma and Application to a Pharmacokinetic Study *
LV S., WANG X., ZHANG X., LI H., WANG B., & ZHANG D. (508)
|
|
|
|
Parameter Optimization and Process Control for the Sterilization of Ornidazole and Sodium Chloride Injection *
YANG Q., MAO K., XIE Z-K., WEI L-H., DENG B., PAN H-C. & LIU H. (513)
|
|
|
|
Role of Linalool in Enantioselective Permeation of Naproxen across Excised Rat Skin *
YU W., ZHANG L., RONG Y., GUO X., & YE J. (522)
|
|
|
|
Characterization and Antimicrobial Activity of Novel Hazelnut Oil Microemulsion Loaded with Mitomycin C *
KOTMAKÇI M., ÖZTÜRK İ, KANTARCI G. & ERMERTCAN Ş. (529)
|
|
|
|
The Molecular Mechanism Involved in the Protective Effect of Etodolac Against Ovarian Injury Induced with Ischemia/Reperfusion in Rats *
AL R.A., YAPCA O.E., DOGAN H., MAMMADOV R., ALTUNER D., SULEYMAN B. & CETIN N. (537)
|
|
|
|
Development of a LC-MS/MS Method for the Determination of Dasatinib in Rat Plasma *
CAO S., WANG X., ZHENG L., SUN M., WANG Y. & FAN R. (542)
|
|
|
|
Pharmacokinetic Study of Remifentanil in Rat Plasma by LCMS/MS *
CHEN S., ZHANG X., WANG G., ZHANG Y., LIU J., TIAN J., & HU J. (547)
|
|
|
|
Effect of Insoluble Excipients on Performance of Direct Compression Controlled Release Matrices *
LAGUNA-LÓPEZ S., ANGULO-DELGADO C.R. & VILLAFUERTE-ROBLES L. (552)
|
|
|
|
Method Development and Validation for Simultaneous Determination of Levofloxacin and Diclofenac Sodium in Pharmaceutical Dosage Form *
FAYYAZ M., YOUSUF R.I., SHOAIB M.H., ALI T., HAIDER S., BUSHRA R., ASHRAF N. & HASSAN S. (562)
|
|
|
|
Skin Lightening and Sebum Control Efficacy of a Cosmetic Emulsion Containing Extract of Tamarind Seeds on Asian Skin Type *
WAQAS M.K., AKHTAR N., BAKHSH S., CALDEIRA E.J. & KHAN B.A. (570)
|
|
|
|
The Effect of Incorporating Gossypol into L-Ascorbyl Palmitate Coagel on Rheological and Viscoelastic Properties *
OKOAMPAH A. & TANG L. (576)
|
|
|
SHORT COMMUNICATIONS |
|
|
High Performance Liquid Chromatographic Determination of C66, a New Curcumin Derviative, in Rat Plasma and its Pharmacokinetic Studies *
XU X., JIANG H., YU Y., HU G., GE R. & CAI Y. (585)
|
|
|
|
Metabolomics-Based Elucidation of Therapeutic Mechanism of Luteolin Towards Autism in Children and Relevant Drug-Drug Interaction Risk *
SUN X., LI C., WANG X., ZHANG R. & HONG Z. (590)
|
|
|
|
Effect of Vera Pammy on Early Healing Strength after Peripheral Nerve Injury Repair *
WU X., HUANG Q., ZHENG H., TIAN J., ZHOU P. & LIU Z. (593)
|
|
|
|
Pharmaceutical Services in Family Health Support Team: the Brazilian Experience *
NAKAMURA C.A. & LEITE S.N. (598)
|
|
|
|
Synthesis and Antibacterial Activities of Two Novel Pyran Annulated Heterocyclic Compounds *
TAN H., ZHANG Y. & WANG R. (602)
|
|
|
|
Determination and Pharmacokinetic Study of Levofloxacin in Human Plasma by HPLC *
PAN C., ZHUGE L., JIN L., WANG Y., ZHOU G., LIN W., ZHANG Q. & CHEN W. (605)
|
|
|
|
Chirality Influence Towards Rivaroxaban-Zidovudine Interaction *
WANG W., LI Y., XIE Z., & XU D. (610)
|
|
|
|
Drug-Drug Interaction between (S)-Rivaroxaban and Orthopedics Treatment Drugs Mainly Undergoing CYP3A4 Metabolism *
SHI J. & GUO Y. (613)
|
|
|
|
The Utilization Risk of Rivaroxaban in the Anti-Glioma Therapy Regimen *
ZHANG H., LIU H., XU F., & ZHANG B. (616)
|
|
|
|
Development of Maple Syrup Urine Disease (MSUD) Therapy Drug for Autism Patients and Safety Evaluation *
SUN X., HU J., QI H., ZHANG R. & HONG Z. (619)
|
|
|
|
Quantification of Lorazepam in Human Plasma Using HPLC: Application to a Pharmacokinetic Study *
FENG J., SHEN R., ZHANG D., DONG Z., ZHANG D., & WANG H. (622)
|
|
|
|
The Risk of Flavonoids Utilization in the Anti-Tumor Therapy *
YU M., GUO Y., WANG J., WANG C., WANG A., ZHANG X., TU Y. & BAI M. (627)
|
|
|
|
Risk Evaluation of Rivaroxaban in the Application of Propofol in Anaesthesia *
KANG Z., YU J., YU H., JIANG Y., CAO Q., & HAN J. (631)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|